№ files_lp_4_process_3_073604
File format: docx
Character count: 12200
File size: 99 KB
This document presents supplementary tables detailing the distribution of participants by self-reported diabetes and anti-diabetic medication use, as well as the incidence rates and hazard ratios for the association of diabetes and glycated hemoglobin with cancer risk across various sites.
Year:
Not specified
Region / City:
UK
Topic:
Diabetes, Glycated Hemoglobin, Cancer Risk
Document Type:
Research Supplementary Table
Institution:
UK Biobank
Author:
Not specified
Target Audience:
Researchers, Healthcare Professionals
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
Not specified
Region / City:
Not specified
Topic:
Health / Medical
Document Type:
Medical guideline
Author:
Not specified
Target Audience:
Healthcare professionals
Action Period:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Author:
Shuchismita Dutta
Institution:
Institute of Quantitative Biomedicine, Rutgers University, Piscataway NJ 08854
Geographic location:
Toms River, New Jersey, United States
Year of case:
2008
Year of publication:
2011
Journal referenced:
New England Journal of Medicine
Related article:
Patch (Toms River edition)
Medical focus:
Cyanosis in a newborn
Genetic focus:
Hemoglobin Toms River mutation (V67M in γ-globin)
Protein studied:
Fetal hemoglobin (α2γ2)
Research methods referenced:
DNA sequencing, structural analysis using Protein Data Bank, laser photolysis, rapid mixing kinetics
Protein database referenced:
Protein Data Bank
Structure visualization tool referenced:
iCn3D
Native protein structure referenced:
PDB ID 4MQJ
Biological system used:
Escherichia coli expression system
Type of document:
Educational case study with research analysis questions
Intended audience:
Students in biochemistry, molecular biology, or biomedical sciences
Subject area:
Molecular basis of cyanosis and hemoglobin mutation
Year:
2007
Region / City:
New Mexico
Topic:
Hemoglobin Function, High-altitude Adaptation, Physiological Studies
Document Type:
Laboratory Instructions, Academic Paper
Organization / Institution:
University of New Mexico
Author:
J.F. Storz
Target Audience:
Students, Researchers in Biology
Period of Action:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2026
Study type:
Observational cohort study
Population:
Surgical patients
Sample size:
8060
Data type:
Clinical, laboratory, perioperative
Variables analyzed:
Demographics, comorbidities, surgical features, intraoperative transfusions, laboratory values, bleeding risk factors, perioperative vasopressors, intravenous fluids, postoperative outcomes
Statistical methods:
Multivariable linear and logistic regression
Outcome measures:
Hospital-free days, ICU-free days, invasive ventilation, mechanical ventilation, acute kidney injury, ICU admission, in-hospital mortality, myocardial and cerebral ischemia
Data collection period:
Not specified
Institution:
Not specified
Source type:
Supplemental tables from clinical research
Year:
2022
Region / city:
Global
Topic:
Hemoglobin concentration, altitude, age-pregnancy groups
Document type:
Research Supplementary Information
Institution:
HemaSphere
Author:
Not specified
Target audience:
Researchers in the field of hematology and epidemiology
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Note:
Description
Data Sharing Agreement between the University of Oxford and Data User for the China Kadoorie Biobank
Year:
2026
Region / City:
Oxford, United Kingdom; Beijing, China
Subject:
Data Sharing, Research Collaboration
Document Type:
Agreement / Contract
Organization:
The Chancellor, Masters and Scholars of the University of Oxford; Peking University
Parties Involved:
Oxford University, Data User
Effective Date:
[as specified in document]
Term:
[from Effective Date to conclusion of Approved Research or specified end date]
Scope:
Access and use of China Kadoorie Biobank data for approved research
Intellectual Property:
Arising Intellectual Property owned by Data User; licence granted to Oxford for teaching and research
Publication Conditions:
Submission of results to Oxford prior to public release
Data Protection:
Compliance required with Schedule 4
Year:
2026
Region / city:
UK
Topic:
Genetics, Mental Health
Document Type:
Research Study
Organization / Institution:
King’s College London, Université Laval
Author:
Genevieve Morneau-Vaillancourt, Jonathan R. I. Coleman, Kirstin L. Purves, Rosa Cheesman, Christopher Rayner, Gerome Breen, Thalia C. Eley
Target Audience:
Researchers, Academics, Healthcare Professionals
Period of Action:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Note:
Contextual Description
Year:
2020
Region / City:
N/A
Theme:
Biobank Protocol, Research Standards
Document Type:
Template
Organization / Institution:
N/A
Author:
N/A
Target Audience:
Researchers, Biobankers
Validity Period:
N/A
Approval Date:
N/A
Modification Date:
N/A
Year:
2018
Region / city:
Belgium
Subject:
Biobank submission to ethics committee
Document type:
Declaration form
Institution:
Ethics committee
Author:
Biobank manager
Target audience:
Biobank managers, ethics committees, research institutions
Date of approval:
Not specified
Date of amendments:
Not specified
Year:
2023
Region / city:
Switzerland
Subject:
Quality management, biobank operations, ISO 20387
Document Type:
Manual
Organization / institution:
Biobank
Author:
Biobank team
Target audience:
Biobank personnel, auditors, customers, external collaborators
Validity Period:
Ongoing
Approval Date:
N/A
Date of Changes:
N/A
Year:
2021
Region / City:
Australia
Subject:
Biobank protocol for research projects
Document type:
Protocol template
Organization:
Various research institutions
Author:
Not specified
Target audience:
Researchers and investigators
Period of validity:
Ongoing
Approval date:
Not specified
Date of changes:
October 2021
Authors:
Jasmine Gratton; Steve E Humphries; Marta Futema
Institutions:
Institute of Cardiovascular Science, Faculty of Population Health Sciences, University College London, London, United Kingdom; Cardiology Research Centre, Molecular and Clinical Sciences Research Institute, St George’s University of London, London, United Kingdom
Country:
United Kingdom
Data source:
UK Biobank
Study design:
Population-based cohort study
Subject:
Prevalence of FH-causing genetic variants and association with LDL-C levels across ancestry groups
Population:
European, South Asian, and African ancestry participants
Sample size:
140,439 European; 4,067 South Asian; 3,906 African participants with lipid and whole exome sequencing data
Genes analysed:
LDLR; APOB; PCSK9
Methods:
Principal component analysis; whole exome sequencing; variant classification using ACMG guidelines
Outcome measures:
Prevalence of pathogenic and likely pathogenic FH variants; LDL-C concentration adjusted for statin use; prevalence and incidence of coronary heart disease
Period of data collection:
2006–2010
Ethical approval:
Conducted under approved UK Biobank application 40721
Type of document:
Scientific research article
Year:
2023
Region / Country:
United Kingdom
Topic:
Air pollution epidemiology
Document type:
Supplementary material / Research dataset description
Institution:
UK Biobank
Data sources:
UKB database, spatio-temporal PM2.5 exposure model
Variables:
Demographics, lifestyle factors, environmental exposures, health outcomes
Methodology:
Cox proportional hazards models with various adjustment strategies
Target population:
UK Biobank participants
Data collection period:
Baseline recruitment and follow-up until 2017
Publication date:
2023
Endnote citation:
Provided in main manuscript reference list
Year:
2023
Region / City:
NSW, Australia
Topic:
Biobank, Inventory Verification, SOP
Document Type:
Standard Operating Procedure
Organization:
NSW Biobank
Author:
NSW Biobank Staff
Target Audience:
Biobank Personnel, Laboratory Technicians, Biobank Managers
Effective Period:
Ongoing
Approval Date:
2023
Modification Date:
Not specified
Note:
Related Documents
NSW/CTRNet Required Operational Practice 6:
Quality Management Systems and Process Improvement
NSW/CTRNet Required Operational Practice 10:
Biospecimen Storage and Retrieval
NSWHSB SOP 4.7:
Biobank Biospecimen Retrieval
NSWHSB SOP 6.2:
Biobank Data Retrieval and Transmission
Materials:
Inventory Management System (Database), Safety Equipment, Ice, Dry Ice, Liquid Nitrogen
Safety:
Follows Institutional Biosafety Guidelines
Type of document:
Supplementary research materials
Research topic:
Cardiovascular health and carotid artery stenosis prevention
Study population:
UK Biobank participants
Sample size:
270,695 participants
Country:
United Kingdom
Dataset:
UK Biobank
Variables examined:
Life’s Essential 8 score, family cardiovascular risk, carotid artery stenosis incidence
Health factors analyzed:
diet, physical activity, nicotine exposure, sleep health, body mass index, blood lipids, blood glucose, blood pressure
Covariates:
age, sex, ethnicity, Townsend deprivation index, alcohol drinking status, education level, income level, employment status, medication use, sedentary time
Disease classification system:
ICD-9 and ICD-10 codes
Statistical methods:
hazard ratios, logistic regression analysis, population attributable risk estimation, sensitivity analysis
Content elements:
disease definitions, covariate definitions, missing data proportions, LE8 component scoring system, stratified analyses, sensitivity analyses, participant selection diagram, score distributions, risk category frequencies, cumulative incidence figures
Document number:
2.02.006
Version:
1.0
Category:
Governance
Sub-category:
Regulatory Affairs
Authored by:
Swiss Biobanking Platform
Effective date:
Not specified
Biobank:
NameProject
Research ID code:
Code
Project Leader/Sponsor or BB Manager/Director:
Name
Key-keeper:
Name & contact
Participant information:
CODE, Last Name, First Name, Date of Birth, Sex
Confidentiality status:
Confidential
Revision history:
Document number 2.02.005, Author SBP, Initial release
Year:
2018
Region:
United Kingdom
Document Type:
Application Form
Organization:
UKCRC Tissue Directory Coordinating Centre (TDCC)
Intended Audience:
Human tissue resource managers and researchers
Submission Requirements:
Maximum of two research case studies
Assessment Criteria:
Impact of research, role of resource, added value, fit-for-purpose, engagement activities
Contact Information:
Main contact details provided in form
Research Type:
Human tissue resource utilization
Format:
Electronic A0 conference poster for case studies